🇺🇸 FDA
Pipeline program

A Study in Healthy Adult Male Participants to Evaluate the Metabolism of [14C]PF-06821497

C2321007

Phase 1 other active

Quick answer

A Study in Healthy Adult Male Participants to Evaluate the Metabolism of [14C]PF-06821497 for small cell lung cancer (SCLC), castration resistant prostate cancer (CRPC), follicular lymphoma (FL) is a Phase 1 program (other) at Pfizer Ireland Pharmaceuticals Unlimited Company with 1 ClinicalTrials.gov record(s).

Program details

Company
Pfizer Ireland Pharmaceuticals Unlimited Company
Indication
small cell lung cancer (SCLC), castration resistant prostate cancer (CRPC), follicular lymphoma (FL)
Phase
Phase 1
Modality
other
Status
active

Clinical trials